ClinicalTrials.Veeva

Menu

Comparison of Sutureless Vs. Standard Biological Prostheses for Surgical Aortic Valve Replacement (COPERA)

S

San Carlos Clinical Hospital

Status

Unknown

Conditions

Heart Valve Prosthesis
Aortic Stenosis
Hemodynamics

Treatments

Device: Conventional stented sutured aortic prosthesis
Device: Sutureless aortic bioprosthesis

Study type

Interventional

Funder types

Other

Identifiers

NCT03965065
19/153-R_P

Details and patient eligibility

About

Multicenter randomised study which aims to compare sutureless Vs. standard bio- prostheses (1:1) among patients undergoing surgical aortic valve replacement in terms of:

  • 6 -month hemodynamic performance.
  • 6 month clinical outcomes including all cause mortality, stroke, myocardial infarction, valve reoperation and major/life threatening bleeding
  • Cost effectiveness

Full description

This study is aimed to compare clinical and hemodynamic performance of conventional sutured stented bio-prostheses among patients undergoing a surgical aortic valve replacement. The prostheses are not pre specified to be provided by a specific manufacturer, so that any bio prosthesis but transcatheter and scentless aortic valves can be implanted.

The estimated sample size is 350 patients. They will be randomised 1:1 to any of the two arms of the study (standard Vs. sutureless prostheses). The randomisation will be stratified according to the need for a concomitant coronary artery bypass grafting procedure.

Six hospitals in Madrid (Spain) will take part in the study. The period of recruitment will start as soon as June 2019 and is supposed to finish by June 2020 or earlier.

The main outcomes of the study will be measured 6 months after the aortic valve implantation

Enrollment

350 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients older than 18
  • Pure aortic stenosis or combined aortic stenosis/regurgitation
  • Aortic annulus >18 mm and < 27 mm

Exclusion criteria

  • Pregnancy
  • Willing to receive some other prosthesis
  • Concomitant surgery of the ascending aorta or left ventricle outflow tract
  • Endocarditis
  • Emergency
  • Some other concomitant procedure
  • Participation in any other study
  • Previous surgery

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

350 participants in 2 patient groups

Sutureless Aortic Valve Prosthesis
Experimental group
Description:
Patients receiving sutureless aortic valve prostheses
Treatment:
Device: Sutureless aortic bioprosthesis
Conventional Aortic Valve Prosthesis
Active Comparator group
Description:
Patients receiving conventional biological aortic prostheses
Treatment:
Device: Conventional stented sutured aortic prosthesis

Trial contacts and locations

1

Loading...

Central trial contact

Manuel Carnero, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems